Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses the affordability of cancer treatments at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. There are various novel agents being developed, however, current costs make some treatments unaffordable. Therefore, there needs to be negotiations with pharmaceutical companies to bring down the costs, and improve the availability of treatments.